Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 45 results.
User Information
Export Records
  1. 1.   A novel patient-derived orthotopic xenograft (PDOX) mouse model of highly-aggressive liver metastasis for identification of candidate effective drug-combinations
  2. Zhang, Zhiying; Hu, Kaiwen; Miyake, Kentaro; Kiyuna, Tasuku; Oshiro, Hiromichi; Wangsiricharoen, Sintawat; Kawaguchi, Kei; Higuchi, Takashi; Razmjooei, Sahar; Miyake, Masuyo; Chawla, Sant P; Singh,Shree Ram; Hoffman, Robert M
  3. Scientific reports. 2020, Nov 18; 10(1): 20105.
  1. 2.   A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib
  2. Yamamoto, Jun; Murata, Takuya; Tashiro, Yoshihiko; Higuchi, Takashi; Sugisawa, Norihiko; Nishino, Hiroto; Inubushi, Sachiko; Sun, Y U; Lim, Hyein; Miyake, Kentaro; Hongo, Atsushi; Nomura, Tsunehisa; Saitoh, Wataru; Moriya, Takuya; Tanino, Hirokazu; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2509-2514.
  1. 3.   Recombinant Methioninase Combined With Tumor-targeting Salmonella typhimurium A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated Liposarcoma
  2. Igarashi, Kentaro; Kawaguchi, Kei; Zhao, Ming; Han, Qinghong; Tan, Yuying; Kiyuna, Tasuku; Miyake, Kentaro; Higuchi, Takashi; Nelson, Scott D; Dry, Sarah M; Li, Yunfeng; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2515-2523.
  1. 4.   Comparison of the Efficacy of EGFR Tyrosine Kinase Inhibitors Erlotinib and Low-dose Osimertinib on a PC-9-GFP EGFR Mutant Non-small-cell Lung Cancer Growing in the Brain of Nude Mice
  2. Katsuya, Yuki; Miyake, Kentaro; Higuchi, Takashi; Oshiro, Hiromichi; Sugisawa, Norihiko; Singh,Shree Ram; Goto, Yasushi; Zhao, Ming; Hoffman, Robert M.
  3. In vivo (Athens, Greece). 2020, May-Jun; 34(3): 1027-1030.
  1. 5.   Pazopanib Inhibits Tumor Growth, Lymph-node Metastasis and Lymphangiogenesis of an Orthotopic Mouse of Colorectal Cancer
  2. Zhu, Guangwei; Zhao, Ming; Han, Qinghong; Tan, Yuying; Sun, Yu; Bouvet, Michael; Singh,Shree Ram; Ye, Jianxin; Hoffman, Robert M.
  3. Cancer genomics & proteomics. 2020, Mar-Apr; 17(2): 131-139.
  1. 6.   Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse model
  2. Park, Jun Ho; Han, Qinghong; Zhao, Ming; Tan, Yuying; Higuchi, Takashi; Yoon, Sang Nam; Sugisawa, Norihiko; Yamamoto, Jun; Bouvet, Michael; Clary, Bryan; Singh,Shree Ram; Hoffman, Robert M
  3. Tissue & cell. 2019, Dec; 61: 109-114.
  1. 7.   Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Oshiro, Hiromichi; Tome, Yasunori; Kiyuna, Tasuku; Yoon, Sang Nam; Lwin, Thinzar M; Han, Qinghong; Tan, Yuying; Miyake, Kentaro; Higuchi, Takashi; Sugisawa, Norihiko; Katsuya, Yuki; Park, Jun Ho; Zang, Zhiying; Razmjooei, Sahar; Bouvet, Michael; Clary, Bryan; Singh,Shree Ram; Kanaya, Fuminori; Nishida, Kotaro; Hoffman, Robert M
  3. Anticancer research. 2019, Sep; 39(9): 4667-4671.
  1. 8.   The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model
  2. Miyake, Kentaro; Higuchi, Takashi; Oshiro, Hiromichi; Zhang, Zhiying; Sugisawa, Norihiko; Park, Jun Ho; Razmjooei, Sahar; Katsuya, Yuki; Barangi, Maryam; Li, Yunfeng; Nelson, Scott D; Murakami, Takashi; Homma, Yuki; Hiroshima, Yukihiko; Matsuyama, Ryusei; Bouvet, Michael; Chawla, Sant P; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2019, SEP; 117: 109093.
  1. 9.   Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse model
  2. Igarashi, Kentaro; Kawaguchi, Kei; Kiyuna, Tasuku; Miyake, Kentaro; Miyake, Masuyo; Nelson, Scott D; Russell, Tara A; Dry, Sarah M; Li, Yunfeng; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Higuchi, Takashi; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Tissue & cell. 2019, Jun; 58: 107-111.
  1. 10.   Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model
  2. Miyake, Kentaro; Murata, Takuya; Murakami, Takashi; Zhao, Ming; Kiyuna, Tasuku; Kawaguchi, Kei; Igarashi, Kentaro; Miyake, Masuyo; Lwin, Thinzar M.; Hozumi, Chihiro; Komatsu, Shin; Kikuchi, Takashi; Bouvet, Michael; Shimoya, Koichiro; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M.
  3. Archives of gynecology and obstetrics. 2019, JUN; 299(6): 1683-1690.
  1. 11.   Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model
  2. Miyake, Kentaro; Kiyuna, Tasuku; Kawaguchi, Kei; Higuchi, Takashi; Oshiro, Hiromichi; Zhang, Zhiying; Wangsiricharoen, Sintawat; Razmjooei, Sahar; Li, Yunfeng; Nelson, Scott D; Murakami, Takashi; Hiroshima, Yukihiko; Matsuyama, Ryusei; Bouvet, Michael; Chawla, Sant P; Singh, Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Cancer chemotherapy and pharmacology. 2019, May; 83(5): 809-815.
  1. 12.   Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model
  2. Miyake, Kentaro; Kiyuna, Tasuku; Miyake, Masuyo; Kawaguchi, Kei; Zhang, Zhiying; Wangsiricharoen, Sintawat; Razmjooei, Sahar; Oshiro, Hiromichi; Higuchi, Takashi; Li, Yunfeng; Nelson, Scott D; Murakami, Takashi; Hiroshima, Yukihiko; Kumamoto, Takafumi; Matsuyama, Ryusei; Bouvet, Michael; Singh, Shree Ram; Chawla, Sant P; Endo, Itaru; Hoffman, Robert M
  3. Biochemical and biophysical research communications. 2019, FEB 19; 509(4): 1041-1046.
  1. 13.   Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft Model
  2. Miyake, Kentaro; Kiyuna, Tasuku; Li, Shukuan; Han, Qinghong; Tan, Yuying; Zhao, Ming; Oshiro, Hiromichi; Kawaguchi, Kei; Higuchi, Takashi; Zhang, Zhiying; Razmjooei, Sahar; Barangi, Maryam; Wangsiricharoen, Sintawat; Murakami, Takashi; Singh, Arun S.; Li, Yunfeng; Nelson, Scott D.; Eilber, Fritz C.; Bouvet, Michael; Hiroshima, Yukihiko; Chishima, Takashi; Matsuyama, Ryusei; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M.
  3. Chemotherapy. 2019, Feb; 63(5): 278-283.
  1. 14.   The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model
  2. Higuchi, Takashi; Kawaguchi, Kei; Miyake, Kentaro; Oshiro, Hiromichi; Zhang, Zhiying; Razmjooei, Sahar; Wangsiricharoen, Sintawat; Igarashi, Kentaro; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Nelson, Scott D; Dry, Sarah M; Li, Yunfeng; Chawla, Sant P; Eilber, Frederick C; Singh, Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2019, Jan 04; 111: 835-840.
  1. 15.   Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP)
  2. Miyake, Kentaro; Kiyuna, Tasuku; Miyake, Masuyo; Zhao, Ming; Wangsiricharoen, Sintawat; Kawaguchi, Kei; Zhang, Zhiying; Higuchi, Takashi; Razmjooei, Sahar; Li, Yunfeng; Nelson, Scott D.; Russell, Tara; Singh, Arun; Murakami, Takashi; Hiroshima, Yukihiko; Momiyama, Masashi; Matsuyama, Ryusei; Chishima, Takashi; Singh,Shree Ram; Chawla, Sant P.; Eilber, Fritz C.; Endo, Itaru; Hoffman, Robert M.
  3. TISSUE & CELL. 2018, OCT; 54: 144-149.
  1. 16.   Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma
  2. Kawaguchi, Kei; Higuchi, Takashi; Li, Shukuan; Han, Qinghong; Tan, Yuying; Igarashi, Kentaro; Zhao, Ming; Miyake, Kentaro; Kiyuna, Tasuku; Miyake, Masuyo; Ohshiro, Hiromichi; Sugisawa, Norihiko; Zhang, Zhiying; Razmjooei, Sahar; Wangsiricharoen, Sintawat; Chmielowski, Bartosz; Nelson, Scott D; Russell, Tara A; Dry, Sarah M; Li, Yunfeng; Eckardt, Mark A; Singh, Arun S; Singh, Shree Ram; Eilber, Fritz C; Unno, Michiaki; Hoffman, Robert M
  3. Biochemical and Biophysical Research Communications. 2018, Sep 18; 503(4): 3086-3092.
  1. 17.   Patterns of Sensitivity to a Panel of Drugs are highly Individualized for Undifferentiated/Unclassified Soft Tissue Sarcoma (USTS) in Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Models
  2. Kawaguchi, Kei; Igarashi, Kentaro; Miyake, Kentaro; Kiyuna, Tasuku; Miyake, Masuyo; Singh, Arun S; Chmielowski, Bartosz; Nelson, Scott D; Russell, Tara A; Dry, Sarah M; Li, Yunfeng; Unno, Michiaki; Singh, Shree Ram; Eilber, Fritz C; Hoffman, Robert M
  3. Journal of drug targeting. 2018, Jul 19; 1-25.
  1. 18.   Recombinant methioninase in combination with DOX overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma
  2. Igarashi, Kentaro; Kawaguchi, Kei; Li, Shukuan; Han, Qinghong; Tan, Yuying; Murakami, Takashi; Kiyuna, Tasuku; Miyake, Kentaro; Miyake, Masuyo; Singh, Arun S; Eckhardt, Mark A; Nelson, Scott D; Russell, Tara A; Dry, Sarah M; Li, Yunfeng; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Tsuchiya, Hiroyuki; Singh, Shree Ram; Eilber, Fritz C; Hoffman, Robert M
  3. Cancer Letters. 2018, MAR 28; 417: 168-173.
  1. 19.   Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin
  2. Day, C. P.; Carter, J.; Bonomi, C.; Hollingshead, M.; Merlino, G.
  3. International Journal of Cancer. 2012, Jan; 130(1): 190-199.
  1. 20.   Characterization, Mapping, and Distribution of the Two XMRV Parental Proviruses
  2. Cingoz, O.; Paprotka, T.; Delviks-Frankenberry, K. A.; Wildt, S.; Hu, W. S.; Pathak, V. K.; Coffin, J. M.
  3. Journal of Virology. 2012, Jan; 86(1): 328-338.
  1. 21.   Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation
  2. Lee, M. H.; Lahusen, T.; Wang, R. H.; Xiao, C.; Xu, X.; Hwang, Y. S.; He, W. W.; Shi, Y.; Deng, C. X.
  3. Oncogene. 2012, Jan; 31(1): 116-127.
  1. 22.   Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts
  2. Alcoser, S. Y.; Kimmel, D. J.; Borgel, S. D.; Carter, J. P.; Dougherty, K. M.; Hollingshead, M. G.
  3. BMC Biotechnology. 2011, Dec; 11
  1. 23.   Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations
  2. Chang, S.; Biswas, K.; Martin, B. K.; Stauffer, S.; Sharan, S. K.
  3. Journal of Clinical Investigation. 2009, Oct; 119(10): 3160-71.
  1. 24.   Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization
  2. Fitzgerald, D. P.; Palmieri, D.; Hua, E.; Hargrave, E.; Herring, J. M.; Qian, Y. Z.; Vega-Valle, E.; Weil, R. J.; Stark, A. M.; Vortmeyer, A. O.; Steeg, P. S.
  3. Clinical & Experimental Metastasis. 2008 25(7): 799-810.
  1. 25.   Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models
  2. Varticovski, L.; Hollingshead, M. G.; Robles, A. I.; Wu, X. L.; Cherry, J.; Munroe, D. J.; Lukes, L.; Anver, M. R.; Carter, J. P.; Borgel, S. D.; Stotler, H.; Bonomi, C. A.; Nunez, N. P.; Hursting, S. D.; Qiao, W. H.; Deng, C. X. X.; Green, J. E.; Hunter, K. W.; Merlino, G.; Steeg, P. S.; Wakefield, L. M.; Barrett, J. C.
  3. Clinical Cancer Research. 2007, Apr; 13(7): 2168-2177.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel